Eton Pharmaceuticals ETON
NASDAQ ETON
$50.18 +0.96 (+1.95%)
As of: Oct 20, 2026 · 3:59 PM EDT

Eton Pharmaceuticals (ETON) EV to EBIT (2023 - 2026)

Updated

Eton Pharmaceuticals' EV to EBIT came in at 80.29 for Q2 2026.

Analysis

Eton Pharmaceuticals (ETON) EV to EBIT (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Eton Pharmaceuticals reported EV to EBIT of 73.17.

  • The Q2 2026 figure represents the highest quarterly EV to EBIT since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Eton Pharmaceuticals 1.39 Bn 1.27 Bn 25.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 80.29
Mar 31, 2024 147.02
Sep 30, 2023 45.59
API Access

Eton Pharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ETON&period=max&api_key=YOUR_API_KEY